The medical devices sector is typified by frequent change and innovation, in response to problems and issues faced by the healthcare industry. As a result, the sector has seen the emergence of several start-up medtech companies offering disruptive, cutting-edge solutions. Most of these are private companies, where data such as revenue is frequently not disclosed. National estimates for Aerogen sales in the US from 2017 to 2023, as well as year-on-year growth rates, can be viewed in GlobalData’s micro revenue report. Buy the report here.
Smarter leaders trust GlobalData
Aerogen Ltd (Aerogen) is a medical device company that designs, manufactures and distributes aerosol drug delivery systems. The company’s products include aerogen solo, a single patient-use micropump nebulizer for aerosol drug delivery; aerogen ultra, a solution for spontaneous breathing patients; aerogen Pro, a nebulizer for treating mechanically ventilated patients, and others. Its products are used in the treatment of various respiratory care diseases such as chronic obstructive pulmonary disease, asthma, and cystic fibrosis. Aerogen serves hospitals including intensive care unit, emergency rooms, wards, and ventilated pediatrics. It distributes its products across Australia, Austria, Belgium, Bulgaria, Canada, China, Cost Rica, Denmark, Egypt and Finland, among others. Aerogen is headquartered in Galway, Ireland. Key subsidiaries of Aerogen include Aerogen Pharma.
The key metrics of Aerogen related to marketed and pipeline products, ongoing clinical trials, active jobs and publications from 2023 are shown below:
As Aerogen is a privately held company, it is not required to disclose its financial information and there is no stock listed on an exchange. GlobalData has access to a proprietary data set containing invoice data from over 2,600 healthcare institutions in the US and is therefore able to use estimations of a company’s revenue and growth to value private companies such as Aerogen.
For a detailed understanding of the performance of Aerogen, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData’s revenue report leverages GlobalData’s SKU tracker, which contains real-world, purchasing data from the US healthcare institutions.
